2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Locally Advanced: new trials by email Literature Review of Locally Advanced trials Research Report on Locally Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas Gemcitabine, AMG 479, Placebo - Adenocarcinoma of the Pancreas, Locally Advanced | Phase 2 | Terminated | NantBioScience, Inc. | 10 | 2012-05-31 | 2024-11-08 |
| QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors AMG 479, AMG 655 - Colorectal Cancer, Locally Advanced | Phase 1 / Phase 2 | Terminated | NantCell, Inc. | 89 | 2009-01-16 | 2024-08-20 |
Pancreatic Neoplasms (2) · Adenocarcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Sarcoma (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Endocrine Gland Neoplasms (2) · Endocrine System Diseases (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Pancreatic Diseases (2) · Adnexal Diseases (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Colonic Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1)
ganitumab (2) · Gemcitabine (1) · conatumumab (1)
NantBioScience, Inc. (1) · NantCell, Inc. (1)
Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · Germany (1) · Hungary (1) · Poland (1) · Portugal (1) · Russia (1) · South Korea (1) · Spain (1) · United Kingdom (1) · United States (1)